• Thiazovivin Product Overview and Evidence Limits

  2026-10-06

  Thiazovivin (SKU A5506) is a supplier-described ROCK inhibitor for stem cell research. No matched paper evidence was provided, so its reported research applications remain unverified within this overview.

• Lopinavir: What Cross-Viral Evidence Really Shows

  2026-10-06

  Lopinavir and ABT-378 are best understood through the relationship between molecular potency, cellular antiviral activity, and evidence provenance. This article examines HIV protease research and the MERS-CoV screening study without overstating what cross-viral findings demonstrate.

• Caspase-3 Fluorometric Assay Kit in Apoptosis Research

  2026-10-05

  A source-grounded overview of DEVD-dependent caspase activity detection, its relevance to apoptosis research, and how the Caspase-3 Fluorometric Assay Kit can be interpreted alongside orthogonal evidence. The discussion emphasizes the findings of Yao et al. in renal cell carcinoma, assay specificity, evidence strength, and applicability limits.

• HyperPFU™ High-Fidelity DNA Polymerase: Evidence

  2026-10-05

  Explore how HyperPFU high-fidelity DNA polymerase supports sequence-accurate analysis of difficult DNA, including GC-rich and long templates. This evidence-focused article connects polymerase fidelity with interpretation of recent base-editing research while defining important applicability limits.

• WZ4003: Interpreting NUAK1/2 Evidence

  2026-10-04

  WZ4003 is a NUAK1/2 inhibitor that connects kinase signaling with cell-cycle, migration, invasion, and tau biology. This evidence-led analysis focuses on how model differences and biomarker choice shape interpretation of its value in cancer research and neurodegeneration.

• LY364947 and TGF-β Signaling: Reading EMT Evidence

  2026-10-03

  Explore how LY364947, a TGF-β type I receptor kinase inhibitor, can frame mechanistic questions about Smad signaling, EMT, and the Wnt/β-catenin pathway. This evidence-focused analysis distinguishes established findings from hypotheses inspired by recent pancreatic cancer research.

• α-Bungarotoxin for Nicotinic Receptor Blockade

  2026-10-01

  Use α-Bungarotoxin to convert α7 receptor involvement from a correlation into a testable pharmacological hypothesis. This workflow connects receptor blockade with cholinergic signaling, necroptosis, inflammation, and trophoblast function while providing practical controls for neuroscience and translational assays.

• TH287 MTH1 Inhibitor for Radiosensitization

  2026-10-01

  TH287 converts MTH1-dependent nucleotide sanitization into a controllable cancer-cell stress model, with particular value in ionizing-radiation studies. A timing-focused workflow helps researchers examine oxidative DNA damage, apoptosis, cell-cycle arrest, and radiosensitization in castration-resistant prostate cancer models.

• Bestatin, Actinonin, and Intracellular Myeloma Effects

  2026-09-30

  The reference study challenges the assumption that bestatin and actinonin inhibit proliferation mainly by blocking cell-surface aminopeptidases. By combining proliferation assays with efflux-modifier experiments, it supports a model in which intracellular drug exposure and transporter activity are central determinants of response.

• Fingolimod (FTY720) in T-Cell Trafficking Assays

  2026-09-30

  Fingolimod (FTY720) provides a controllable way to interrogate S1P-dependent lymphocyte trafficking alongside magnetically guided CAR-T-mimicking cell platforms. This workflow-focused guide separates egress inhibition, T-cell activation, tumor-cell toxicity, and CNS signaling so combination experiments remain interpretable rather than assuming improved tumor infiltration.

• Ampicillin Sodium: Mechanism and Research Use

  2026-09-29

  Ampicillin sodium is a β-lactam antibiotic used to study bacterial cell wall biosynthesis inhibition and antibacterial activity. The A2510 product is reported at 98% purity, with product-dossier benchmarks of 1.8 μg/mL against transpeptidase in E. coli 146 cells and a 3.1 μg/mL MIC.

• Benzyl-activated Streptavidin Magnetic Beads

  2026-09-29

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnet-assisted capture of biotinylated proteins, peptides, antibodies, oligonucleotides, nucleic acids, and related targets from complex samples. They are not intended for direct capture of non-biotinylated targets, and preservative or BSA carryover must be controlled when samples are used for live-cell, enzymatic, or highly sensitive analytical workflows.

• HyperScript™ Reverse Transcriptase for Translational qPCR

  2026-09-28

  A mechanistic and strategic guide to selecting reverse transcriptase chemistry for structured RNA, scarce templates, and translational qPCR workflows—anchored in recent Moloney murine leukemia virus assay research.

• Thiazovivin: Practical ROCK Inhibitor Workflow

  2026-09-28

  Thiazovivin is a ROCK inhibitor used to support fibroblast reprogramming during induced pluripotent stem cell generation and human embryonic stem cell survival after trypsinization. It is intended for controlled research workflows, not diagnostic, medical, or clinical use; the product dossier does not provide a working concentration or a directly matched paper dataset.

• ECL Chemiluminescent Substrate Detection Kit for OSCC

  2026-09-27

  Translate evidence on CAF-derived fatty acids and oral cancer signaling into a practical Western blot plan for targets such as caveolin-1 and PI3K/AKT pathway proteins. The hypersensitive HRP substrate supports low-picogram-range detection, reduced background, and a longer imaging window for carefully optimized immunoblots.

8696 records 1/580 page Next 12345 下5页 Last page